BioNTech SE Sponsored ADR
(NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

98.680

-0.390 (-0.39%)
Range 96.380 - 98.865   (2.58%)
Open 97.540
Previous Close 99.070
Bid Price 116.800
Bid Volume 12
Ask Price 116.990
Ask Volume 8
Volume 597,978
Value -
Remark
Delayed prices. Updated at 24 May 2025 04:00.
Data powered by
View All Events
Share your investing ideas
Please login to view stock data and analysis